Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6

被引:59
作者
Camus, S.
Menendez, S.
Cheok, C. F.
Stevenson, L. F.
Lain, S.
Lane, D. P.
机构
[1] Inst Mol & Cell Biol, Dept Cell Cycle Control, Proteos 138673, Singapore
[2] Univ Dundee, Dept Surg & Mol Oncol, Dundee DD1 4HN, Scotland
[3] Ninewells Hosp & Med Sch, Dundee, Scotland
关键词
ubiquitination; p53; human papillomavirus; E6; degradation; proteasome;
D O I
10.1038/sj.onc.1210188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vitro, high-risk human papillomavirus E6 proteins have been shown, in conjunction with E6-associated protein (E6AP), to mediate ubiquitination of p53 and its degradation by the 26S proteasome by a pathway that is thought to be analogous to Mdm2-mediated p53 degradation. However, differences in the requirements of E6/E6AP and Mdm2 to promote the degradation of p53, both in vivo and in vitro, suggest that these two E3 ligases may promote p53 degradation by distinct pathways. Using tools that disrupt ubiquitination and degradation, clear differences between E6-and Mdm2-mediated p53 degradation are presented. The consistent failure to fully protect p53 protein from E6-mediated degradation by disrupting the ubiquitin-degradation pathway provides the first evidence of an E6-dependent, ubiquitin-independent, p53 degradation pathway in vivo.
引用
收藏
页码:4059 / 4070
页数:12
相关论文
共 53 条
[1]   The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes [J].
Benaroudj, N ;
Tarcsa, E ;
Cascio, P ;
Goldberg, AL .
BIOCHIMIE, 2001, 83 (3-4) :311-318
[2]   INVOLVEMENT OF THE 20S-PROTEASOME IN THE DEGRADATION OF ORNITHINE DECARBOXYLASE [J].
BERCOVICH, Z ;
KAHANA, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (01) :205-210
[3]   Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6 [J].
Camus, S ;
Higgins, M ;
Lane, DP ;
Lain, S .
FEBS LETTERS, 2003, 536 (1-3) :220-224
[4]  
Chen Z, 2004, SHOCK, V21, P1
[5]   ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY [J].
CHOWDARY, DR ;
DERMODY, JJ ;
JHA, KK ;
OZER, HL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1997-2003
[6]   Antizyme, a mediator of ubiquitin-independent proteasomal degradation [J].
Coffino, P .
BIOCHIMIE, 2001, 83 (3-4) :319-323
[7]   ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 [J].
Courtois, S ;
Verhaegh, G ;
North, S ;
Luciani, MG ;
Lassus, P ;
Hibner, U ;
Oren, M ;
Hainaut, P .
ONCOGENE, 2002, 21 (44) :6722-6728
[8]   Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6 [J].
Crook, T ;
Ludwig, RL ;
Marston, NJ ;
Willkomm, D ;
Vousden, KH .
VIROLOGY, 1996, 217 (01) :285-292
[9]   Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells [J].
Dalal, S ;
Gao, QS ;
Androphy, EJ ;
Band, V .
JOURNAL OF VIROLOGY, 1996, 70 (02) :683-688
[10]   THE ABILITY OF HUMAN PAPILLOMAVIRUS E6 PROTEINS TO TARGET P53 FOR DEGRADATION IN-VIVO CORRELATES WITH THEIR ABILITY TO ABROGATE ACTINOMYCIN D-INDUCED GROWTH ARREST [J].
FOSTER, SA ;
DEMERS, GW ;
ETSCHEID, BG ;
GALLOWAY, DA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :5698-5705